If you are considering a changewhether for convenience, availability, or personal preferenceit is crucial to match the dosing as closely as possible and to understand that differences in absorption, efficacy, and safety may exist
For example, the synergy between GLP-1 and continuous glucose monitoring (CGM) devices is expected to significantly improve diabetes management and disease prevention
Therefore, if you are trying to split the dose, it may increase the following risks: Microdosing is associated with a higher chance of inaccurate dosing (too little or too much dose)
For many people, the question isnt whether GLP-1 medications work
This history often supports the need for medical intervention
Common microdosing approaches The following are the common microdosing approaches: Sustained low dose: Some individuals remain indefinitely on the initial starter dose, such as 0.25 mg of semaglutide weekly, and never exceed this dose